Find Clinical Trials
Servier Protocol Code:
CL2-16257-053
Sponsor:
Institut de Recherches Internationales Servier
Clinicaltrials.gov Identifier:
NCT00202579
Find a recruiting site
How to participate in this study
If you think you are eligible for this study (see
below), you can identify the location closest to you and contact them directly. If you can’t find a location close to you, please contact Institut de Recherches Internationales Servier (I.R.I.S.)
eligibility criteria
Researchers look for people who fit a certain decription, called eligibility criteria. These include inclusion criteria and exclusion criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
The study has 1 location
Study description
To evaluate the effects on heart function of ivabradine administered to patients with severe chronic heart failure
Official title: Evaluation of the Effects on Peripheral and Central Haemodynamics Parameters, Safety, and Tolerance of Three-hour Intravenous Perfusion (0.1 mg/kg) of Ivabradine Given to Severe Congestive Heart Failure Patients
Results
English (USA)Conditions
Heart Failure, Congestive
Interventions / Treatments
The treatment(s) given to the participants in the study.
- Ivabradine
Other study id numbers
Other identification numbers the study may be known by.
- CL2-16257-053
Eligibility Criteria
Researchers look for people who fit a certain decription, called eligibility criteria. These include inclusion criteria and exclusion criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligible age for the study
18 years to 75 years
(Adult, Older Adult)
Sex
Male/FemaleAccepts Healthy Volunteers
No- * systolic congestive heart failure
- * sinus rhythm, HR >= 80bpm
- * unstable cardiovascular condition
How is the study designed?
Allocation
How participants are assigned to different groups. Allocation can be random (randomized) or predetermined (non-randomized). Randomized means that participants are assigned at random to their participant group / arm.
Interventional study model
How treatments are given and tested in a study.
Single Group
A single group study design involves studying one group of participants who all receive the same treatment. Researchers observe the group's results to understand the effects of the treatment.
Keywords
Additional Relevant MeSH Terms Glioma
Heart Failure